← Open Payments lookup

COURTNEY WUSS: Open Payments

NPI 1326593286 · LAKEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,591 in 97 payments from 13 companies in 2025. Trend: 2023 $5,069 · 2024 $2,297 · 2025 $1,591

Food & beverage: $1,591
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)25$485
ABBVIE INC.20$265
Teva Pharmaceuticals USA, Inc.20$192
Otsuka America Pharmaceutical, Inc.12$156
Madrigal Pharmaceuticals1$142
Neurocrine BioSciences, Inc.5$107
Alkermes, Inc.5$88
Axsome Therapeutics, Inc.2$35
Braeburn Inc.2$33
Almatica Pharma LLC2$31

Products named: CAPLYTA, VRAYLAR, AUSTEDO XR, REZDIFFRA, REXULTI, INGREZZA, ARISTADA, Auvelity.

Industry payments across NJ — which companies pay providers there.